BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 15547528)

  • 1. Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.
    Scordalakes C; delRosario R; Shimer A; Stankiewicz R
    Int J Womens Health; 2018; 10():137-145. PubMed ID: 29713204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.
    Miller JD; Lenhart GM; Bonafede MM; Basinski CM; Lukes AS; Troeger KA
    Int J Womens Health; 2015; 7():59-73. PubMed ID: 25610002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: impact on patients' health-related quality of life.
    Bongers MY; Bourdrez P; Heintz AP; Brölmann HA; Mol BW
    Fertil Steril; 2005 Mar; 83(3):724-34. PubMed ID: 15749505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.
    Xie H; Wan Y; Yi S; Zeng F; Sun X; Yang Y; Xiao S
    Int J Gynaecol Obstet; 2022 Aug; 158(2):301-307. PubMed ID: 34653258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year literature review of global endometrial ablation with the NovaSure® device.
    Gimpelson RJ
    Int J Womens Health; 2014; 6():269-80. PubMed ID: 24648771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of Uterine Fibroids and Their Management, Surgical Management of Fibroids, Laparoscopy and Hysteroscopy versus Hysterectomy, Haemorrhage, Adhesions, and Complications.
    Mettler L; Schollmeyer T; Tinelli A; Malvasi A; Alkatout I
    Obstet Gynecol Int; 2012; 2012():791248. PubMed ID: 22619681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of treatment outcomes after global endometrial ablation.
    El-Nashar SA; Hopkins MR; Creedon DJ; St Sauver JL; Weaver AL; McGree ME; Cliby WA; Famuyide AO
    Obstet Gynecol; 2009 Jan; 113(1):97-106. PubMed ID: 19104365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis.
    Tu X; Huang G; Tan S
    Evid Based Complement Alternat Med; 2009 Mar; 6(1):99-105. PubMed ID: 18955223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal uterine bleeding: a review of patient-based outcome measures.
    Matteson KA; Boardman LA; Munro MG; Clark MA
    Fertil Steril; 2009 Jul; 92(1):205-16. PubMed ID: 18635169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial ablation with NovaSure GEA, a pilot study.
    Busund B; Erno LE; Grønmark A; Istre O
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
    Fulop T; Rákóczi I; Barna I
    J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation endometrial ablation treatment: Novasure.
    Bongers MY
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment of surgical therapies for benign gynaecological disease.
    Owusu-Ansah R; Gatongi D; Chien PF
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):841-79. PubMed ID: 17145485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
    Gallinat A
    Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
    Gallinat A
    J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.